<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3183">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01926301</url>
  </required_header>
  <id_info>
    <org_study_id>83743712</org_study_id>
    <nct_id>NCT01926301</nct_id>
  </id_info>
  <brief_title>Cerebrovascular Autoregulation in Sepsis, Influence of Renal Replacement Therapy</brief_title>
  <acronym>SepsAR2</acronym>
  <official_title>Cerebrovascular Autoregulation in Patients With Severe Sepsis and Septic Shock, Influence of Renal Replacement Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johannes Gutenberg University Mainz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johannes Gutenberg University Mainz</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The cerebrovascular autoregulation is impaired in patients with severe sepsis and septic
      shock. A continuous veno-venous hemodialysis may improve impaired cerebrovascular
      autoregulation.

      Hypothesis: continuous hemodialysis recovers impaired cerebrovascular autoregulation in
      patients with acute severe sepsis and septic shock.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">August 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Cerebrovascular autoregulation</measure>
    <time_frame>during the first 4 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Cerebrovascular autoregulation measured daily at the first 4 days of severe sepsis and septic shock</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Delirium</measure>
    <time_frame>at day 4</time_frame>
    <safety_issue>No</safety_issue>
    <description>Incidence of Delirium at day 4 after severe sepsis or septic shock</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">47</enrollment>
  <condition>Severe Sepsis</condition>
  <condition>Septic Shock</condition>
  <arm_group>
    <arm_group_label>Hemodialysis</arm_group_label>
    <description>Patients with severe sepsis or septic shock with acute renal failure and requirement of continuous veno-venous hemodialysis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No hemodialysis</arm_group_label>
    <description>Patients with severe sepsis or septic shock without acute renal failure and no requirement of continuous veno-venous hemodialysis</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>continuous veno-venous hemodialysis</intervention_name>
    <arm_group_label>Hemodialysis</arm_group_label>
    <other_name>Renal replacement therapy</other_name>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum and whole blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with severe sepsis or septic shock at the intensive care unit of an university
        general hospital
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  severe sepsis or septic shock

          -  adult patients

          -  possibility of transcranial Doppler ultrasound

        Exclusion Criteria:

          -  traumatic brain injury

          -  known cerebrovascular diseases

          -  Infection of the brain

          -  chronic renal failure

          -  pregnancy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patrick Schramm, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Medical Center of the Johannes Gutenberg-University Mainz, Germany</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Patrick Schramm, MD</last_name>
    <phone>00496131176755</phone>
    <email>schrammp@uni-mainz.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Medical Center of the Johannes Gutenberg-Univerity</name>
      <address>
        <city>Mainz</city>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick Schramm, MD</last_name>
      <phone>00496131176755</phone>
      <email>schrammp@uni-mainz.de</email>
    </contact>
    <investigator>
      <last_name>Patrick Schramm, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>August 17, 2013</lastchanged_date>
  <firstreceived_date>August 17, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Johannes Gutenberg University Mainz</investigator_affiliation>
    <investigator_full_name>Patrick Schramm</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>sepsis</keyword>
  <keyword>cerebrovascular autoregulation</keyword>
  <keyword>delirium</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
    <mesh_term>Shock</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
